Exact sciences corporation (EXAS)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue

347,821

295,575

218,805

199,870

162,043

142,981

118,291

102,894

90,296

87,406

72,574

57,646

48,363

35,241

28,115

21,185

14,835

14,420

12,632

8,119

4,266

1,504

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product royalty fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

7

License fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

294

1,036

1,036

1,036

1,036

-

-

-

-

-

-

-

-

1,351

1,307

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,504

0

0

294

1,036

-

-

-

1,036

1,036

1,036

1,036

1,042

1,039

1,042

1,040

1,356

1,314

Gross margin

-

-

-

-

-

-

-

-

-

63,911

51,845

39,655

31,382

21,376

15,941

11,088

5,776

6,753

5,104

3,025

54

-1,897

-924

0

294

1,036

-

-

-

1,036

1,036

1,036

1,036

1,036

1,033

1,036

1,034

1,350

1,308

Cost of sales (exclusive of amortization of acquired intangible assets)

81,606

70,416

52,335

51,139

42,827

37,827

29,685

26,553

22,579

23,495

20,729

17,991

16,981

13,865

12,174

10,097

9,059

7,667

7,528

5,094

4,212

3,401

924

-

-

-

-

-

-

-

-

-

-

6

6

6

6

6

6

Research and development

43,509

43,223

34,714

29,972

31,785

20,700

17,400

14,481

14,704

12,675

11,725

9,737

8,002

7,082

7,625

8,640

10,126

9,365

9,863

8,115

6,571

4,992

9,073

7,174

7,430

6,713

6,982

6,457

7,526

10,439

10,491

12,202

8,999

7,672

6,110

5,197

2,989

2,635

2,123

Sales and marketing

167,749

119,851

86,196

88,190

90,939

76,773

64,836

54,431

53,408

40,627

37,768

36,728

38,801

30,506

26,308

30,301

25,711

21,944

23,079

20,593

16,524

15,069

13,217

6,166

4,456

2,902

1,615

3,302

1,759

1,824

1,006

1,331

594

1,094

815

651

297

315

330

General and administrative

113,991

144,414

80,472

63,641

63,806

56,263

46,693

39,529

35,531

33,598

30,763

24,609

20,070

21,498

20,292

17,284

17,824

15,864

15,432

13,683

12,971

10,625

8,994

6,230

4,586

3,687

3,686

3,628

2,648

2,815

2,547

2,393

2,145

2,206

1,951

1,830

2,150

1,796

1,339

Amortization of acquired intangible assets

23,339

13,779

748

748

760

734

602

602

602

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

430,194

539,257

201,706

138,995

230,117

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30,686

31,284

19,570

16,472

13,302

12,283

13,387

11,933

-

-

-

-

-

-

-

-

4,746

3,792

Loss from operations

-82,373

-96,108

-35,660

-33,820

-68,074

-49,316

-40,925

-32,702

-36,528

-22,989

-28,411

-31,419

-35,491

-37,710

-38,284

-45,137

-47,885

-40,420

-43,270

-39,366

-36,012

-32,583

-32,208

-19,570

-16,178

-12,266

-11,247

-12,351

-10,897

-14,042

-13,008

-14,890

-10,702

-9,936

-7,843

-6,642

-4,402

-3,396

-2,484

Other income (expense)
Investment income, net

97

3,113

9,093

7,669

6,655

6,321

6,292

4,917

3,673

1,320

1,334

683

595

592

535

425

466

491

365

193

222

150

160

146

86

96

103

55

62

74

67

59

62

38

75

22

34

19

12

Interest expense

-25,153

-13,688

-13,209

-12,712

-21,990

-10,972

-10,704

-8,603

-6,510

-51

-51

-54

-50

-52

-54

-53

-54

-62

-40

107

-11

11

-12

-13

15

16

16

18

19

20

11

5

5

6

5

5

5

5

5

Total other income (expense)

-25,056

-10,575

-4,116

-5,043

-15,335

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

139

148

133

71

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss before tax

-107,429

-106,683

-39,776

-38,863

-83,409

-53,967

-45,337

-36,388

-39,365

-21,720

-27,128

-30,790

-34,946

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit

-1,700

-184,628

683

-443

-500

7

27

-1

59

44

-231

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-105,697

77,945

-40,459

-38,420

-82,939

-53,974

-45,364

-36,387

-39,424

-21,764

-26,897

-30,790

-34,946

-37,170

-37,803

-44,765

-47,473

-39,991

-42,945

-39,066

-35,801

-32,444

-32,060

-19,437

-16,107

-12,186

-11,160

-12,314

-10,854

-13,988

-12,952

-14,836

-10,645

-9,904

-7,773

-6,625

-4,373

-3,382

-2,477

Net loss per share - basic and diluted (in usd per share)

-0.71

0.62

-0.31

-0.29

-0.66

-0.44

-0.37

-0.30

-0.33

-0.18

-0.23

-0.27

-0.32

-0.34

-0.36

-0.46

-0.49

-0.41

-0.45

-0.44

-0.40

-0.38

-0.39

-0.24

-0.23

-0.17

-0.16

-0.19

-0.17

-0.22

-0.21

-0.26

-0.19

-0.18

-0.15

-0.13

-0.08

-0.08

-0.06

Weighted average common shares outstanding - basic and diluted (in shares)

148,151

139,996

129,586

129,198

126,248

122,981

122,671

122,129

121,016

119,950

119,215

112,847

110,582

109,274

104,807

97,902

97,246

96,404

94,444

88,919

88,662

84,734

82,941

82,048

70,987

70,757

70,559

64,699

63,836

63,582

60,531

57,037

56,718

53,647

52,443

52,010

51,930

-

-

Weighted average common shares outstanding-basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,155

39,067

Weighted average common shares outstanding-diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,155

39,067